000950 重藥控股
按盤價 
5.700 +0.230 (+4.205%)
5.700 +0.230 (+4.205%) | 2024/09 - 九個月 | 2023/12 | 2022/12 | 2021/12 | 2020/12 | 盈利能力分析 |
| 淨資產收益率 ROE (%) | 2.577 | 5.982 | 9.303 | 10.778 | 10.460 |
| 總資產報酬率 ROA (%) | 0.449 | 1.085 | 1.782 | 2.183 | 2.604 |
| 投入資產回報率 ROIC (%) | 0.774 | 1.793 | 2.795 | 3.409 | 2.937 | 邊際利潤分析 |
| 銷售毛利率 (%) | 7.435 | 7.874 | 8.581 | 9.178 | 9.364 |
| 營業利潤率 (%) | 0.918 | 1.257 | 2.116 | 2.497 | 3.033 |
| 息稅前利潤/營業總收入 (%) | 2.280 | 2.884 | 3.784 | 4.267 | 4.591 |
| 淨利潤/營業總收入 (%) | 0.682 | 0.964 | 1.715 | 2.064 | 2.537 | 收益指標分析 |
| 經營活動淨收益/利潤總額(%) | 115.929 | 107.832 | 82.894 | 86.852 | 84.026 |
| 價值變動淨收益/利潤總額(%) | 45.508 | 31.502 | 20.079 | 27.183 | 22.222 |
| 營業外收支淨額/利潤總額(%) | -0.181 | 0.143 | 2.545 | 1.225 | 0.224 | 償債能力分析 |
| 流動比率 (X) | 1.289 | 1.273 | 1.198 | 1.303 | 1.292 |
| 速動比率 (X) | 1.065 | 1.088 | 1.004 | 1.112 | 1.084 |
| 資產負債率 (%) | 76.601 | 75.588 | 77.776 | 76.325 | 75.301 |
| 帶息債務/全部投入資本 (%) | 68.491 | 66.893 | 69.010 | 66.250 | -- |
| 股東權益/帶息債務 (%) | 42.674 | 46.169 | 42.106 | 47.097 | 49.389 |
| 股東權益/負債合計 (%) | 22.415 | 23.421 | 23.946 | 25.890 | 27.653 |
| 利息保障倍數 (X) | 1.672 | 1.775 | 2.346 | 2.453 | 2.959 | 營運能力分析 |
| 應收賬款周轉天數 (天) | 154.791 | 137.903 | 144.535 | 137.356 | 0.000 |
| 存貨周轉天數 (天) | 43.892 | 38.500 | 40.388 | 37.100 | 0.000 |
| 備註： | 報價延遲最少15分鐘，資料更新時間為 18/11/2024 13:05 |
- 經濟通
- 強化版MQ
- 強化版TQ
- 財曆
- Mobile
Web
